We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALO icon
1576
Talos Energy
TALO
$2.79B
$393K ﹤0.01%
+25,156
New +$348K
ALEX
1577
DELISTED
Alexander & Baldwin
ALEX
$390K ﹤0.01%
21,290
-15,499
-42% -$286K
PTON icon
1578
Peloton Interactive
PTON
$2.35B
$390K ﹤0.01%
+3,148
New +$335K
SSRM icon
1579
SSR Mining
SSRM
$7.77B
$390K ﹤0.01%
+25,039
New +$421K
BWFG icon
1580
Bankwell Financial Group
BWFG
$523M
$387K ﹤0.01%
+13,995
New +$392K
TECH icon
1581
Bio-Techne
TECH
$11.4B
$387K ﹤0.01%
3,436
-293,308
-99% -$30.9M
COKE icon
1582
Coca-Cola Consolidated
COKE
$12.9B
$386K ﹤0.01%
9,590
+1,370
+17% +$48.3K
CD
1583
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$386K ﹤0.01%
25,569
-993,274
-97% -$14.9M
NVAX icon
1584
Novavax
NVAX
$1.52B
$385K ﹤0.01%
1,815
-12,780
-88% -$2.34M
SIGA icon
1585
SIGA Technologies
SIGA
$221M
$384K ﹤0.01%
+61,199
New +$420K
SPRU icon
1586
Spruce Power Holding Corp
SPRU
$38.5M
$384K ﹤0.01%
+5,769
New +$340K
LXP icon
1587
LXP Industrial Trust
LXP
$3.6B
$381K ﹤0.01%
+6,382
New +$388K
AKR icon
1588
Acadia Realty Trust
AKR
$2.89B
$380K ﹤0.01%
17,284
+6,253
+57% +$133K
CYH icon
1589
Community Health Systems
CYH
$412M
$380K ﹤0.01%
+24,601
New +$334K
CFB
1590
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$380K ﹤0.01%
+27,615
New +$399K
BL icon
1591
BlackLine
BL
$1.82B
$379K ﹤0.01%
3,407
-1,848
-35% -$202K
FIRY
1592
Firy Inc
FIRY
$161M
$379K ﹤0.01%
+874
New +$312K
GPRO icon
1593
GoPro
GPRO
$110M
$378K ﹤0.01%
+32,480
New +$366K
ZEUS
1594
DELISTED
Olympic Steel
ZEUS
$377K ﹤0.01%
+12,825
New +$404K
AIRG icon
1595
Airgain
AIRG
$70.1M
$376K ﹤0.01%
18,225
-14,406
-44% -$297K
ENS icon
1596
EnerSys
ENS
$6.96B
$376K ﹤0.01%
3,850
-14,664
-79% -$1.37M
FCN icon
1597
FTI Consulting
FCN
$4.19B
$376K ﹤0.01%
+2,755
New +$388K
BRY
1598
DELISTED
Berry Corp
BRY
$375K ﹤0.01%
+55,772
New +$353K
LSPD icon
1599
Lightspeed Commerce
LSPD
$1.36B
$374K ﹤0.01%
4,471
-5,180
-54% -$364K
PAC icon
1600
Grupo Aeroportuario del Pacifico
PAC
$12.8B
$374K ﹤0.01%
3,501
+788
+29% +$85.7K

Similar funds

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.